Mochida President Hopes to Ease Impact of Next NHI Price Revision with New Drugs

January 24, 2012
Naoyuki Mochida, President, Mochida Pharmaceutical Mochida Pharmaceutical President Naoyuki Mochida told reporters at a meeting on January 23 in Tokyo that by enforcing additional price cuts for long-listed products, which comprise 70-80% of his company products, the next NHI price...read more